Debra Barker has been named chief medical officer (CMO) at Centauri Therapeutics (Nasdaq: IPSC), a UK immunotherapy company ...

Switzerland-based MetP Pharma, pioneer in nose-to-brain drug delivery for nearly two decades, announced new data highlighting ...

Diagonal Therapeutics, a US biotech focused on correcting dysregulated signaling with clustering antibodies that address the ...

The US subsidiary of South Korea-based Celltrion today announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) ...

US biotech Cogent Biosciences closed Monday’s trading 23% higher, following the company’s announcement of positive top-line ...

Having appointed Renée Aguiar-Lucander as its chief executive in April and Maria Törnsén as chief operating officer a month ...

US CAR-T focused biotech CARGO Therapeutics today announced that it has entered into a definitive merger agreement with ...

Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also ...

Otsuka subsidiary Taiho Pharmaceuticals earlier announced that the results of a Phase III, randomized, placebo-controlled, ...

Shares of US clinical-stage biotech Apogee Therapeutics closed down 17.3% at $39.24 yesterday, despite announcing positive 16 ...

French biotech Nanobiotix’ (shares were up nearly 7% at 4.44 euros in early trading, after the company announced two important developments that aim to reinforce the global positioning of potential ...

Eli Lilly (NYSE: LLY) led the way in pharma M&A during June. The US pharma major announced two major deals in the month, both ...